StonvexLoading…
StonvexStonvexStonvexCore line items from OGEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|
Revenue | $37.65K | $131.52K | $86.99K |
Operating Income | $-20.90M | $-14.42M | $-15.77M |
Net Income | $-20.66M | $-14.29M | $-15.71M |
EPS (Diluted) | $-9.18 | $-7.11 | $-8.09 |
Total Assets | $4.97M | $14.76M | $28.23M |
Total Liabilities | $1.80M | Not available | Not available |
Cash & Equivalents | $3.48M | $11.43M | $27.27M |
Free Cash Flow OCF − CapEx | Not available | $-15.36M | $-13.51M |
Shares Outstanding | 3.08M | 2.02M | 2.00M |